We identified known and novel ADAM10-regulated signalling mechanisms, with prominent effects being associated with the tumour microenvironment, including blood vessels, ECM organisation, and differentiation, and the expression of the associated protein signatures also correlated with ADAM10 expression in human tumours. The gene discussed is ADAM10; the disease is neoplasm.